Analystreport

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) had its price target raised by analysts at Piper Sandler from $30.00 to $32.00.

NGM Biopharmaceuticals, Inc.  (NGM) 
Last ngm biopharmaceuticals, inc. earnings: 3/17 04:05 pm Check Earnings Report